• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

FDA fi­nal­izes guid­ance on us­ing EHR da­ta to sup­port drug sub­mis­sions

10 months ago
FDA+

Rare pe­di­atric PRV reau­tho­riza­tion faces un­cer­tain fate as sum­mer re­cess ap­proach­es

10 months ago
FDA+
Law

In a tough mar­ket, pri­vate biotechs pur­sue IPOs and buy­outs at the same time

10 months ago
Financing
Startups

No­var­tis pays $150M up­front, in­clud­ing $25M in eq­ui­ty, for Dren Bio’s bis­pecifics

10 months ago
Deals

BioN­Tech signs 3D print­ing deal to de­vel­op oral RNA drugs

10 months ago
Deals

Palvel­la’s re­verse merg­er with Pieris; Ab­b­Vie’s VC arm in­vests in an­ti-ag­ing start­up 

10 months ago
News Briefing

BeiGene plots to fur­ther build its man­u­fac­tur­ing mus­cle out­side of Chi­na

10 months ago
China
Manufacturing

Pfiz­er touts Phase 3 gene ther­a­py da­ta in he­mo­phil­ia A, but now it needs to prove it can win the mar­ket

10 months ago
R&D

Sage's es­sen­tial tremor drug fails in an­oth­er blow to pipeline, Bio­gen part­ner­ship

10 months ago
R&D

Chi­nese biotech de­vel­op­ing semaglu­tide biosim­i­lar files for Hong Kong IPO

10 months ago
Financing
China

With new mis­sion in psy­chi­a­try, Au­to­bahn rais­es $100M to help back Phase 2 work

10 months ago
Financing

Ac­tivist in­vestor calls for board shake­up at As­ser­tio, threat­ens proxy con­test

10 months ago
Pharma

Ex­clu­sive: RA Cap­i­tal in­vests $35M in UK can­cer biotech Cell­Cen­tric

10 months ago
Financing
R&D

As­traZeneca signs pre­clin­i­cal EGFR drug deal with an­ti­body biotech

10 months ago
Deals
R&D

PBM ex­ec­u­tives dodge grilling in House com­mit­tee hear­ing

10 months ago
Pharma
Law

FDA asks ad­comm if As­traZeneca needs an­oth­er study on Imfinzi be­fore and af­ter lung can­cer surgery

10 months ago
Pharma
FDA+

Ab­b­Vie files law­suit in Mis­souri fed­er­al court over 340B con­tract phar­ma­cies

10 months ago
Pharma
Law

What's changed about rare dis­ease med­i­cine

10 months ago
R&D

In­di­an man­u­fac­tur­er Bras­si­ca hit with warn­ing let­ter af­ter em­ploy­ees faked da­ta re­sults

10 months ago
FDA+
Manufacturing

Up­dat­ed: Mer­ck, with­out shar­ing de­tails, says RSV an­ti­body suc­cess­ful­ly pro­tect­ed in­fants

10 months ago
R&D
Pharma

Pfiz­er lifts cur­tain on $740M+ ex­ten­sion at API man­u­fac­tur­ing site in Sin­ga­pore

10 months ago
Pharma
Manufacturing

Cel­lec­tar to seek ap­proval for ra­dioac­tive io­dine-based ther­a­py in rare blood can­cer

10 months ago
R&D

Neu­rol­o­gy start­up from Or­biMed col­lab nabs $65M in Se­ries A

10 months ago
Financing
Startups

Telix's $397M con­vert­ible bond of­fer­ing; Scynex­is records a $10M mile­stone

10 months ago
News Briefing
First page Previous page 127128129130131132133 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times